Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Carsten Kamphues

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5406-8540; OpenAlex author ID A5074875010. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
45
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 3 papers · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. Diagnostic Performance of Node-RADS for CT-based Assessment of Regional Lymph Nodes in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-9115727/v1↗
  2. Performance of the 7 th and 8 th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Ass… Co-author DOI 10.1097/sla.0000000000005313↗
  3. The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/ijms24032160↗
  4. Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma. Co-author DOI 10.1007/s00411-022-00962-w↗
  5. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model. Co-author DOI 10.1200/cci.21.00001↗
  6. Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. Last author DOI 10.3390/biology10101033↗
  7. Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14010201↗
  8. Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture. Last author DOI 10.1186/s12885-020-06929-8↗
  9. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicat… Co-author DOI 10.1097/mpa.0000000000000248↗
  10. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000077↗
  11. High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/1471-2407-13-450↗
  12. High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer. Co-author DOI 10.1111/j.1365-2559.2012.04225.x↗
  13. Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Co-author DOI 10.1245/s10434-011-2041-4↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Katharina Beyer · 7 shared papers, 2020–2023 · strength 0.93
  2. Florian Nino Loch · 5 shared papers, 2020–2026 · strength 0.80
  3. Georgios Antonios Margonis · 5 shared papers, 2020–2023 · strength 0.59
  4. Marcus Bahra · 6 shared papers, 2012–2026 · strength 0.44
  5. Frederick Klauschen · 7 shared papers, 2012–2021 · strength 0.40
  6. Mihnea Paul Dragomir · 2 shared papers, 2021–2023 · strength 0.30
  7. Simon Schallenberg · 2 shared papers, 2021–2023 · strength 0.30
  8. Rolf Reiter · 1 shared paper, 2026 · strength 0.27
  9. Ingolf Sack · 1 shared paper, 2026 · strength 0.27
  10. Ioannis Pozios · 2 shared papers, 2021–2022 · strength 0.27
  11. Alessandra Pulvirenti · 2 shared papers, 2021–2023 · strength 0.24
  12. Christopher Lee Wolfgang · 2 shared papers, 2021–2023 · strength 0.24
  13. Matthew John Weiss · 2 shared papers, 2021–2023 · strength 0.24
  14. Hendrik Seeliger · 2 shared papers, 2021–2022 · strength 0.24
  15. Albrecht Stenzinger · 5 shared papers, 2012–2015 · strength 0.17
  16. Carlos F. Fernandez-del Castillo · 1 shared paper, 2023 · strength 0.15
  17. Peter J. Allen · 1 shared paper, 2023 · strength 0.15
  18. Kevin C. Soares · 1 shared paper, 2023 · strength 0.15
  19. Vicente Morales‐Oyarvide · 1 shared paper, 2023 · strength 0.15
  20. Lucas D. Lee · 1 shared paper, 2022 · strength 0.15
  21. Christiane J. Bruns · 1 shared paper, 2022 · strength 0.15
  22. Wilko Weichert · 4 shared papers, 2012–2015 · strength 0.14
  23. Bruno Valentin Sinn · 4 shared papers, 2012–2015 · strength 0.14
  24. Oliver Klein · 1 shared paper, 2021 · strength 0.13
  25. Fiona Speichinger · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.